GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (NYSE:WST) » Definitions » Shiller PE Ratio

West Pharmaceutical Services (West Pharmaceutical Services) Shiller PE Ratio : 76.84 (As of Apr. 25, 2024)


View and export this data going back to 1980. Start your Free Trial

What is West Pharmaceutical Services Shiller PE Ratio?

As of today (2024-04-25), West Pharmaceutical Services's current share price is $372.68. West Pharmaceutical Services's E10 for the quarter that ended in Dec. 2023 was $4.85. West Pharmaceutical Services's Shiller PE Ratio for today is 76.84.

The historical rank and industry rank for West Pharmaceutical Services's Shiller PE Ratio or its related term are showing as below:

WST' s Shiller PE Ratio Range Over the Past 10 Years
Min: 29.46   Med: 65.36   Max: 165.26
Current: 76.84

During the past years, West Pharmaceutical Services's highest Shiller PE Ratio was 165.26. The lowest was 29.46. And the median was 65.36.

WST's Shiller PE Ratio is ranked worse than
86.91% of 275 companies
in the Medical Devices & Instruments industry
Industry Median: 27.09 vs WST: 76.84

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

West Pharmaceutical Services's adjusted earnings per share data for the three months ended in Dec. 2023 was $1.830. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $4.85 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


West Pharmaceutical Services Shiller PE Ratio Historical Data

The historical data trend for West Pharmaceutical Services's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Shiller PE Ratio Chart

West Pharmaceutical Services Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.84 122.41 144.14 57.23 72.61

West Pharmaceutical Services Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.23 80.34 84.75 79.46 72.61

Competitive Comparison of West Pharmaceutical Services's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Pharmaceutical Services's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where West Pharmaceutical Services's Shiller PE Ratio falls into.



West Pharmaceutical Services Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

West Pharmaceutical Services's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=372.68/4.85
=76.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

West Pharmaceutical Services's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, West Pharmaceutical Services's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.83/129.4194*129.4194
=1.830

Current CPI (Dec. 2023) = 129.4194.

West Pharmaceutical Services Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.380 99.695 0.493
201406 0.520 100.560 0.669
201409 0.430 100.428 0.554
201412 0.430 99.070 0.562
201503 0.450 99.621 0.585
201506 0.380 100.684 0.488
201509 0.020 100.392 0.026
201512 0.450 99.792 0.584
201603 0.300 100.470 0.386
201606 0.600 101.688 0.764
201609 0.500 101.861 0.635
201612 0.520 101.863 0.661
201703 0.810 102.862 1.019
201706 0.510 103.349 0.639
201709 0.670 104.136 0.833
201712 0.000 104.011 0.000
201803 0.580 105.290 0.713
201806 0.750 106.317 0.913
201809 0.730 106.507 0.887
201812 0.690 105.998 0.842
201903 0.730 107.251 0.881
201906 0.880 108.070 1.054
201909 0.750 108.329 0.896
201912 0.840 108.420 1.003
202003 0.990 108.902 1.177
202006 1.210 108.767 1.440
202009 1.090 109.815 1.285
202012 1.290 109.897 1.519
202103 1.990 111.754 2.305
202106 2.470 114.631 2.789
202109 2.310 115.734 2.583
202112 1.930 117.630 2.123
202203 2.290 121.301 2.443
202206 2.480 125.017 2.567
202209 1.590 125.227 1.643
202212 1.360 125.222 1.406
202303 1.850 127.348 1.880
202306 2.060 128.729 2.071
202309 2.140 129.860 2.133
202312 1.830 129.419 1.830

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


West Pharmaceutical Services  (NYSE:WST) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


West Pharmaceutical Services Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


West Pharmaceutical Services (West Pharmaceutical Services) Business Description

Traded in Other Exchanges
Address
530 Herman O. West Drive, Exton, PA, USA, 19341-0645
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Executives
Chad Winters officer: VP, CAO & Controller 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Charles Witherspoon officer: VP & Treasurer 530 HERMAN O WEST DRIVE, EXTON PA 19341
Annette F Favorite officer: Sr. VP Human Resources Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Cindy Reiss-clark officer: Senior Vice President 530 HERMAN O. WEST DRIVE, EXTON PA 19341-1147
Quintin J Lai officer: VP Corp Development & Strategy 530 HERMAN 0. WEST DRIVE, EXTON PA 19341
Silji Abraham officer: Chief Digital & Trans Officer 5000 TOWN CENTER, U, SOUTHFIELD MI 48075
Eric Mark Green officer: Chief Executive Officer 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Bernard Birkett officer: Sr VP, CFO & Treasurer 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas W Hofmann director FIVE RADNOR CORPORATE CENTER, SUITE 500, RADNOR PA 19087
Stephen H Lockhart director C/O NATIONAL RESEARCH CORPORATION, 1245 Q STREET, LINCOLN NE 68508
Molly Joseph director 9209 GRAND SUMMIT BLVD, DRIPPING SPRINGS TX 78620
Kimberly Banks Mackay officer: SVP, GC & Corporate Secretary 530 HERMAN O. WEST DRIVE, EXTON PA 19341
George Lloyd Miller officer: Sr. VP, GC & Corp. Sec. 530 HERMAN O. WEST DRIVE, EXTON PA 19341
David A Montecalvo officer: SVP, Glob Ops and Supply Chain 530 HERMAN O. WEST DRIVE, EXTON PA 19341
Robert F Friel director 940 WINTER STREET, WALTHAM MA 02451